Amygdala enlargement in patients with mesial temporal lobe epilepsy without hippocampal sclerosis

被引:37
|
作者
Coan, Ana Carolina [1 ]
Morita, Marcia Elisabete [1 ]
de Campos, Brunno Machado [1 ]
Yasuda, Clarissa Lin [1 ]
Cendes, Fernando [1 ]
机构
[1] Univ Estadual Campinas, Dept Neurol, Neuroimaging Lab, Campinas, SP, Brazil
来源
FRONTIERS IN NEUROLOGY | 2013年 / 4卷
基金
巴西圣保罗研究基金会;
关键词
amygdala; temporal lobe epilepsy; MRI-negative; volumetry; voxel-based morphometry;
D O I
10.3389/fneur.2013.00166
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose: Patients with mesial temporal lobe epilepsy (MTLE) without MRI abnormalities (MTLE-NL) represent a challenge for definition of underlying pathology and for presurgical evaluation. In a recent study we observed significant amygdala enlargement (AE) in 14% of MILE patients with MRI signs of hippocampal sclerosis. Areas of gray matter volume (GMV) increase could represent structural abnormalities related to the epileptogenic zone or part of a developmental abnormality. Our objective was to look for undetected areas of increased GMV in MILE-NL using post processing MRI techniques to better understand the pathophysiology of this condition. Methods: We evaluated 66 patients with MILE-NL on visual analysis and 82 controls. Voxel-based morphometry (VBM) group analysis was performed with VBM8/SPM8 looking for areas of increased GMV. We then performed automatic amygdala volumetry using FreeSurfer software and T2 relaxometry to confirm VBM findings. Results: Voxel-based morphometry group-analysis demonstrated increased amygdala volume in the MILE-NL group compared to controls. Individual volumetric analysis confirmed AE in eight (12%) patients. Overall, from all patients with AE and defined epileptic focus, four (57%) had the predominant increased volume ipsilateral to the epileptic focus. These results were cross-validated by a secondary VBM analysis including subgroups of patients according to the volumetric data. T2 relaxometry demonstrated no amygdala hyperintense signal in any individual with significant AE. There were no clinical differences between patients with and without AE. Discussion: This exploratory study demonstrates the occurrence of AE in 12% of patients with MILE-NL. This finding supports the hypothesis that there might be a subgroup of patients with MILE-NL in which the enlarged amygdala could be related to the epileptogenic process. Further studies are necessary but this finding could be of great importance in the understanding of MILE-NL.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Thalamic diffusion and volumetry in temporal lobe epilepsy with and without mesial temporal sclerosis
    Gong, Gaolang
    Concha, Luis
    Beaulieu, Christian
    Gross, Donald W.
    EPILEPSY RESEARCH, 2008, 80 (2-3) : 184 - 193
  • [22] Differential gene expression in dentate granule cells in mesial temporal lobe epilepsy with and without hippocampal sclerosis
    Griffin, Nicole G.
    Wang, Yu
    Hulette, Christine M.
    Halvorsen, Matt
    Cronin, Kenneth D.
    Walley, Nicole M.
    Haglund, Michael M.
    Radtke, Rodney A.
    Skene, J. H. Pate
    Sinha, Saurabh R.
    Heinzen, Erin L.
    EPILEPSIA, 2016, 57 (03) : 376 - 385
  • [23] ApoE ε4 is not associated with posictal confusion in patients with mesial temporal lobe epilepsy with hippocampal sclerosis
    Andres Kauffman, Marcelo
    Pereira-de-Silva, Nahuel
    Consalvo, Damian
    Kochen, Silvia
    EPILEPSY RESEARCH, 2009, 85 (2-3) : 311 - 313
  • [24] Interleukin-1 beta secretion in hippocampal sclerosis patients with mesial temporal lobe epilepsy
    Dundar, Nihal Olgac
    Aktekin, Berrin
    Ekinci, Nilufer Cicek
    Sahinturk, Duygu
    Yavuzer, Ugur
    Yegin, Olcay
    Haspolat, Senay
    NEUROLOGY INTERNATIONAL, 2013, 5 (03) : 58 - 61
  • [25] Depression in patients with temporal lobe epilepsy is related to mesial temporal sclerosis
    Quiske, A
    Helmstaedter, C
    Lux, S
    Elger, CE
    EPILEPSY RESEARCH, 2000, 39 (02) : 121 - 125
  • [26] Neuroimaging observations linking neurocysticercosis and mesial temporal lobe epilepsy with hippocampal sclerosis
    Bianchin, Marino M.
    Velasco, Tonicarlo R.
    Wichert-Ana, Lauro
    Araujo, David, Jr.
    Alexandre, Veriano, Jr.
    Scornavacca, Francisco
    Escorsi-Rosset, Sara R.
    dos Santos, Antonio Carlos
    Carlotti, Carlos G., Jr.
    Takayanagui, Osvaldo M.
    Sakamoto, Americo C.
    EPILEPSY RESEARCH, 2015, 116 : 34 - 39
  • [27] Mesial temporal lobe epilepsy with hippocampal sclerosis is infrequently associated with neuronal autoantibodies
    Nobrega-, Adaucto W., Jr.
    Gregory, Christian P.
    Schlindwein-Zanini, Rachel
    Neves, Fabricio de Souza
    Wolf, Peter
    Walz, Roger
    Steindel, Mario
    Lin, Katia
    EPILEPSIA, 2018, 59 (09) : E152 - E156
  • [28] Cytokine-chemokine profiles in the hippocampus of patients with mesial temporal lobe epilepsy and hippocampal sclerosis
    Aulicka, Stefania
    Ceska, Katarina
    Sana, Jiri
    Siegl, Frantisek
    Brichtova, Eva
    Oslejskova, Hana
    Hermanova, Marketa
    Hendrych, Michal
    Michu, Elleni Ponechal
    Brazdil, Milan
    Slaby, Ondrej
    Nestrasil, Igor
    EPILEPSY RESEARCH, 2022, 180
  • [29] Altered immune pathways in patients of temporal lobe epilepsy with and without hippocampal sclerosis
    Che, Xiang-Qian
    Zhan, Shi-Kun
    Song, Jiao-Jiao
    Deng, Yu-Lei
    Sun, Zhan-Fang
    Che, Zai-Qian
    Liu, Jun
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [30] Hemicranial volume deficits in patients with temporal lobe epilepsy with and without hippocampal sclerosis
    Briellmann, RS
    Jackson, GD
    Kalnins, R
    Berkovic, SF
    EPILEPSIA, 1998, 39 (11) : 1174 - 1181